Matches in Wikidata for { <http://www.wikidata.org/entity/Q64680438> ?p ?o ?g. }
Showing items 1 to 30 of
30
with 100 items per page.
- Q64680438 description "clinical trial" @default.
- Q64680438 description "ensayu clínicu" @default.
- Q64680438 description "klinisch onderzoek" @default.
- Q64680438 description "клінічне випробування" @default.
- Q64680438 name "Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older" @default.
- Q64680438 type Item @default.
- Q64680438 label "Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older" @default.
- Q64680438 prefLabel "Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older" @default.
- Q64680438 P1132 Q64680438-85B9F3D9-6953-486A-9ABF-AE089691990F @default.
- Q64680438 P1476 Q64680438-8880A145-1D5F-461F-A091-3F57C9F883D7 @default.
- Q64680438 P17 Q64680438-AD29EFB9-F308-4976-81B5-D8B3C8755BCC @default.
- Q64680438 P2899 Q64680438-6C4F5A98-88E5-4FDE-A324-AE0271BDC849 @default.
- Q64680438 P3098 Q64680438-C926CBA2-6C2C-4620-90E1-FCEA4FB37BF7 @default.
- Q64680438 P31 Q64680438-B799A999-BD4D-4B7C-BDE2-10D5B3C57EB6 @default.
- Q64680438 P580 Q64680438-C230A8D3-BA5E-4808-BBFD-9814C1334241 @default.
- Q64680438 P582 Q64680438-2CCF2507-9992-4E92-94EE-956210AE6684 @default.
- Q64680438 P6099 Q64680438-94091D90-BD65-4D45-9A7A-BE958FA36E9F @default.
- Q64680438 P8363 Q64680438-7B0AA64E-EE18-4FA2-AFFA-02B6DCE06863 @default.
- Q64680438 P921 Q64680438-9EAB86BF-3CD0-4AD8-AE77-CA98EF65F3BE @default.
- Q64680438 P1132 "+450" @default.
- Q64680438 P1476 "A Phase Ib, Multi-Center, Randomized, Observer-Blind, Proof of Concept, Dose- and Formulation-Ranging Study to Evaluate Safety, Tolerability, and Immunogenicity of One Dose of Trivalent Inactivated Influenza Vaccine in Different Presentations (Intramuscular and Intradermal Delivery), Dosages (Regular or Higher A/H3N2 Content) and Doses of Adjuvant Administered to Healthy Elderly Aged ≥ 65 Years" @default.
- Q64680438 P17 Q31 @default.
- Q64680438 P2899 "+65" @default.
- Q64680438 P3098 "NCT00848848" @default.
- Q64680438 P31 Q30612 @default.
- Q64680438 P580 "2008-10-01T00:00:00Z" @default.
- Q64680438 P582 "2009-04-01T00:00:00Z" @default.
- Q64680438 P6099 Q5452194 @default.
- Q64680438 P8363 Q78089383 @default.
- Q64680438 P921 Q18971653 @default.